Parents' Intentions and Associated Factors to Vaccinating Their Children Aged 12-17 Years with COVID-19 Vaccines: A Cross Sectional Study.

Vaccines (Basel)

Department of Public Health and Community Medicine, Menoufia Faculty of Medicine, Menoufia University, Shebin Al-Kom 6131567, Egypt.

Published: June 2022

No available vaccine against COVID-19 had yet been proven for 12-17-year-olds in Egypt during the study period. This is the first study to assess Egyptian parents' intentions and associated factors in relation to vaccinating their children with COVID-19 vaccines. A cross-sectional study using a questionnaire was conducted between 17 October and 17 November 2021, via social media platforms. The target group was parents with children aged 12-17 years. Parents' intention to vaccinate their children and factors associated with vaccinating their children, reasons for not intending to vaccinate their children, and circumstances whereby the parents would change their mind were recorded. Among the 1458 parents recruited, 65.6% were planning to vaccinate their children. The main concerns were fear of the vaccine's side-effects (68.3%) and conspiracy theories (18%). The factors associated with parents' intention to vaccinate their children were mother's older age (40-49 years: aOR = 1.45, 95% CI = 1.05-1.99; ≥50 years: aOR = 2.09, 95% CI = 1.16-3.75), high family income (aOR = 1.99, 95% CI = 1.41-2.79), and children with a history of chronic conditions (aOR = 2.02, 95% CI = 1.25-3.25), while higher mother's education level was negatively associated (aOR = 0.41, 95% CI = 0.27, 0.64). A comprehensive health education program regarding vaccinating children with COVID-19 vaccines is highly recommended for parents, particularly for young and highly educated mothers, to enhance children vaccination rate when the vaccine becomes available.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231357PMC
http://dx.doi.org/10.3390/vaccines10060912DOI Listing

Publication Analysis

Top Keywords

vaccinating children
16
vaccinate children
16
covid-19 vaccines
12
children
11
parents' intentions
8
intentions associated
8
associated factors
8
children aged
8
aged 12-17
8
12-17 years
8

Similar Publications

Introduction: Infants and young children typically have the highest age-related risk of invasive meningococcal disease. The immunogenicity and safety of a single primary dose and a booster of a meningococcal A/C/W/Y tetanus toxoid conjugate vaccine (MenACWY-TT; Nimenrix) in infants were evaluated.

Methods: In this phase 3b, open-label, single-arm study, healthy 3-month-old infants received a single Nimenrix dose followed by a booster at age 12 months (1 + 1 series).

View Article and Find Full Text PDF

An Update on Multi-System Inflammatory Syndrome in Children.

Curr Rheumatol Rep

January 2025

Division of Rheumatology, Department of Pediatrics, The Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI, 02903, USA.

Purpose: To summarize the latest research on the epidemiology, pathogenesis, diagnosis, and treatment of multisystem inflammatory syndrome in children (MIS-C).

Recent Findings: The epidemiology of MIS-C has been dynamic since its initial description. The pathogenesis remains poorly understood.

View Article and Find Full Text PDF

Pneumococcal vaccines in China.

Hum Vaccin Immunother

December 2025

Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Research Units of Innovative Vaccine Quality Evaluation and Standardization, Chinese Academy of Medical Sciences, National Institutes of Food and Drug Control, Beijing, People's Republic of China.

Invasive pneumococcal disease (IPD) is a serious global public health problem and the leading cause of morbidity and mortality in children and adults in China. Thus, developing and administering pneumococcal vaccines are important for disease prevention. The PPV23 and PCV13 vaccines are available in the Chinese market and are primarily produced by domestic manufacturers.

View Article and Find Full Text PDF

Purpose Of Review: The densely populated Asia Pacific region is home to 600 million children, and suffers from a significant burden of morbidity and mortality due to infections associated with antimicrobial resistance (AMR). We aimed to identify the drivers, challenges and potential opportunities to alter the burden of AMR within the region.

Recent Findings: Despite the high AMR burden borne by the Asia Pacific region, there are limited (and geographically imbalanced) published data to delineate the contemporary epidemiology of serious multidrug-resistant bacterial infections in children.

View Article and Find Full Text PDF

Biallelic pathogenic variants in the inorganic pyrophosphatase 2 (PPA2) gene are a rare but established cause of sudden infant death, which may be precipitated by a pyrexial or viral illness. It has also been associated with sudden death secondary to alcohol ingestion in young adults. We describe the case of a thirteen-month-old female who presented following out-of- hospital cardiac arrest and was subsequently diagnosed with compound, heterozygous pathogenic variants of PPA2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!